Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of [18F] F-FAPI PET-CT on Management in Patients With Potentially Resectable Biliary Tract Cancers: Prospective Multicenter Study and Cost-effectivity Analysis

NCT06355427 is registered in ClinicalTrials.gov with Mara Veenstra, MD as lead sponsor.

NCT NCT06355427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06355427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of [18F] F-FAPI PET-CT on Management in Patients With Potentially Resectable Biliary Tract Cancers: Prospective Multicenter Study and Cost-effectivity Analysis
Lead sponsor
Mara Veenstra, MD
Phase
Phase 2/3
Overall status
Recruiting
Start date
November 29, 2024
Completion date
February 1, 2028
Enrollment
81 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma